Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 3Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Follicular 2Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Crohn Disease 1Colitis, Ulcerative 1Anemia 1

Interventions

Epoetin Alfa 10fludarabine phosphate 3Darbepoetin alfa 3Cyclophosphamide 3fludarabine 2ferric carboxymaltose 2Thiotepa 2Therapeutics 2Filgrastim 2Ferric Oxide, Saccharated 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2AP 1903 reagent 2venetoclax 1trametinib 1thymoglobulin 1siltuximab 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1obinutuzumab 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia × Iron-Dextran Complex × Lymphoid × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡